Skip to content

disease.nz

Your Daily Health News
Main navigation
Medical Editor October 10, 2020

Takeda strikes $1B biobucks deal with Arrowhead for genetic liver disease asset – FierceBiotech

Takeda strikes $1B biobucks deal with Arrowhead for genetic liver disease asset  FierceBiotech
Bookmark the permalink.

Recent Posts

  • Mum of teen with rheumatic heart disease urges vigilance of sore throats – Stuff.co.nz
  • Model shows sharp decrease in HIV incidence in England
  • US research article claims whiteness is a ‘malignant, parasitic-like condition’ with no cure – Newshub
  • A vital tool to study virus evolution in the test tube
  • Warmer temperatures lessen COVID-19 spread, but control measures still needed, study finds

Recent Comments

    |
    Footer navigation
    • Privacy Policy